Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2019 Aug 22;10(9):633. doi: 10.1038/s41419-019-1866-9

Retraction Note: HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation

Shixiu Sun 1,2, Yujie Zhang 1,3, Jianchao Zheng 1,4, Biao Duan 1, Jie Cui 5,6, Yan Chen 6, Wenjie Deng 1, Bixing Ye 7, Lei Liu 5,6, Yongchang Chen 8, Jun Du 1,3,, Luo Gu 1,3,6,
PMCID: PMC6706401  PMID: 31439830

Retraction Note to: Cell Death & Disease 9:929

10.1038/s41419-018-0931-0 published online 11 September 2018

This article was published in error and has been retracted at the request of the authors. During the proofing stage, the authors found that some lanes in Figs. 2b, 2h, 3h and S4a were not the appropriate ones. Shixiu Sun, Yujie Zhang, Jianchao Zheng, Biao Duan, Yan Chen, Wenjie Deng, Bixing Ye, Lei Lui, Yongchang Chen, Jun Du and Luo Gu agree with this retraction. We have been unable to contact Jie Cui. The authors have been given the opportunity to submit a revised manuscript for peer review.

Footnotes

Edited by G. Ciliberto

The original article can be found online at 10.1038/s41419-018-0931-0.

Contributor Information

Jun Du, Email: dujun@njmu.edu.cn.

Luo Gu, Email: lgu@njmu.edu.cn.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES